Dr Reddy’s Receives USFDA Nod For Omeprazole

Dr Reddy'sDomestic pharmaceutical major Dr Reddy's Laboratories Ltd has finally received approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application or ANDA, for its over-the-counter drug Omeprazole Mg.

Omeprazole is the generic version of AstraZeneca PLC's Prilosec. It is indscated for the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and Zollinger-Ellison syndrome.

The Hyderabad, India-based company said that first shipment of Omeprazole Mg would start during the second quarter of the next year (2010).

Nicaragua grants asylum to Peruvian indigenous leader

Alberto PizangoManagua/Lima  - Nicaragua on Tuesday granted asylum to Alberto Pizango, the leader of Peru's indigenous community who had taken refuge in the Nicaraguan embassy in Lima after clashes between police and indigenous demonstrators.

Nicaraguan authorities considered Pizango as being "persecuted" by the government of Peruvian President Alan Garcia, Nicaragua's Ambassador in Peru Tomas Borge said in Managua.

Borge said the decision was made by Nicaraguan President Daniel Ortega, after Pizango sought refuge Monday in the Nicaraguan Embassy in Lima.

Qatar to Have Stake in Porche

Lanxess to acquire GCIL for Rs. 536 crore

Gwalior Chemicals Industries Ltd. German based chemical manufacturer, Lanxess is all set to acquire Gwalior Chemicals Industries (GCIL) for Rs. 536 crore subjected to the approval of shareholders. The deal is likely to be completed by September 30.

DIAL gets Rs200 crore by leasing out 4.55 acres

Omaxe to raise Rs1,800 crore, hikes FII limit to 40%

Omaxe to raise Rs1,800 crore, hikes FII limit to 40%Omaxe, a leading real estate developer of the country, has been working out plans to raise funds worth Rs 1800 crore through different modes. In addition, the developer has decided to increase the FII limit in the company to 40% from 24% in a bid to attract foreign investment in the company. 

The firm is also working out plans to issue securities, on private placement basis, to qualified institutional buyers (QIBs) under its fund raising plans for which it has already received shareholder's approval.

Pages

News in Focus

ARK Innovation UCITS ETF Gains as Coinbase, Tesla and Palantir Technologies Stocks Jump

The ARK Innovation UCITS ETF (ISIN: IE000GA3D489) is an actively managed fund focusing on global equities poised to benefit from disruptive innovation.

Palantir Technologies (NYSE: PLTR) Stock Price at All-Time Highs; Technical Review

Palantir Technologies Incorporated (NYSE: PLTR), a prominent player in the data analytics and artificial intelligence sectors, has recently garnered significant attention due to its strategic initi

Mufin Green Finance Reports Robust Q2 Growth, Driven by Higher Revenues

Mufin Green Finance, a key player in financing green energy initiatives, has delivered a strong financial performance for the September quarter, reporting a net profit of ₹6 crore.

Starbucks Corporation (NASDAQ: SBUX) HOLD Ratings Maintained by Argus Research

Argus Research has maintained its HOLD rating for Starbucks Corp. (NASDAQ: SBUX), reflecting challenges in customer traffic, supply chain pressures, and rising labor costs.

International Game Technology (NYSE: IGT) Stock Price Target Suggested at $25 by Argus Research

Argus Research has reiterated its BUY recommendation for International Game Technology PLC (NYSE: IGT) with a target price of $25, offering a potential upside of over 20% from its recent closing pr

Evolution and FanDuel Extend Strategic Partnership: Live Casino Leadership Reinforced

Evolution, the leading B2B casino solution provider, announced a three-year extension of its partnership with FanDuel Casino, solidifying its role as the exclusive provider of live dealer casino ga